Vibegron

Last Updated: 04/28/2026

Need to find the closest trial?
Sort By Distance
Save trials for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
2 clinical trials found

    Impact of Early Aging and Menopause on the Vascular Responses to Hypoxia

    Impact of Early Aging and Menopause on the Vascular Responses to Hypoxia

    Enrollment Status: Recruiting
    Publish Date: September 09, 2025
    Intervention Type: Drug
    Study Phase: Early Phase 1

    Summary: The purpose of this study is to examine hypoxic vasodilation and the role of beta-adrenergic receptors in younger premenopausal, perimenopausal, and older postmenopausal women.

    A Phase 2/3, Open-label, Baseline-controlled, Multicenter, Long-term Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Vibegron in Pediatric Subjects 2 Years to < 18 Years of Age With Neurogenic Detrusor Overactivity (NDO) on Clean Intermittent Catheterization (CIC)

    A Phase 2/3, Open-label, Baseline-controlled, Multicenter, Long-term Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Vibegron in Pediatric Subjects 2 Years to < 18 Years of Age With Neurogenic Detrusor Overactivity (NDO) on Clean Intermittent Catheterization (CIC)

    Enrollment Status: Recruiting
    Publish Date: July 03, 2024
    Intervention Type: Drug
    Study Phase: Phase 2/Phase 3

    Summary: The purpose of this study is to evaluate the safety, efficacy, and PK of vibegron in pediatric participants with NDO who are regularly using CIC

    Showing 1-2 of 2

    Last Updated: 04/28/2026